Evidence map›Paper›PMID 35629389›Full record

ArticleLife (Basel, Switzerland)2022

Criteria for Verification and Replanning Based on the Adaptive Radiotherapy Protocol "Best for Adaptive Radiotherapy" in Head and Neck Cancer.

Bartosz Bak, Agnieszka Skrobala, Anna Adamska, Joanna Kazmierska, Natalia Jozefacka, Tomasz Piotrowski, Julian Malicki

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Current Role of Delta Radiomics in Head and Neck Oncology.International journal of molecular sciences · 2023
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bartosz BakDepartment of Electroradiology, Poznan University of Medical Science, 61-866 Poznan, Poland.ORCID 0000-0003-4567-4917
Agnieszka SkrobalaDepartment of Electroradiology, Poznan University of Medical Science, 61-866 Poznan, Poland.
Anna AdamskaDepartment and Radiotherapy Ward I, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Joanna KazmierskaDepartment of Electroradiology, Poznan University of Medical Science, 61-866 Poznan, Poland.
Natalia JozefackaInstitute of Psychology, Pedagogical University in Krakow, 30-084 Krakow, Poland.ORCID 0000-0002-1674-3760
Tomasz PiotrowskiDepartment of Electroradiology, Poznan University of Medical Science, 61-866 Poznan, Poland.ORCID 0000-0002-8894-7412
Julian MalickiDepartment of Electroradiology, Poznan University of Medical Science, 61-866 Poznan, Poland.ORCID 0000-0002-5558-5558
Poznan University of Medical Sciences · PLGreater Poland Cancer Center · PLUniwersytet Komisji Edukacji Narodowej w Krakowie · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

No clear criteria have yet been established to guide decision-making for patient selection and the optimal timing of adaptive radiotherapy (ART) based on image-guided radiotherapy (IGRT). We have developed a novel protocol—the Best for Adaptive Radiotherapy (B-ART) protocol—to guide patient selection for ART. The aim of the present study is to describe this protocol, to evaluate its validity in patients with head and neck (HN) cancer, and to identify the anatomical and clinical predictors of the need for replanning. We retrospectively evaluated 82 patients with HN cancer who underwent helical tomotherapy (HT) and subsequently required replanning due to soft tissue changes upon daily MVCT. Under the proposed criteria, patients with anatomical changes >3 mm on three to four consecutive scans are candidates for ART. We compared the volumes on the initial CT scan (iCT) and the replanning CT (rCT) scan for the clinical target volumes (CTV1, referring to primary tumor or tumor bed and CTV2, metastatic lymph nodes) and for the parotid glands (PG) and body contour (B-body). The patients were stratified by primary tumor localization, clinical stage, and treatment scheme. The main reasons for replanning were: (1) a planning target volume (PTV) outside the body contour (n = 70; 85.4%), (2) PG shrinkage (n = 69; 84.1%), (3) B-body deviations (n = 69; 84.1%), and (4) setup deviations (n = 40; 48.8%). The replanning decision was made, on average, during the fourth week of treatment (n = 47; 57.3%). The mean reductions in the size of the right and left PG volumes were 6.31 cc (20.9%) and 5.98 cc (20.5%), respectively (p < 0.001). The reduction in PG volume was ≥30% in 30 patients (36.6%). The volume reduction in all of the anatomical structures was statistically significant. Four variables—advanced stage disease (T3−T4), chemoradiation, increased weight loss, and oropharyngeal localization—were significantly associated with the need for ART. The B-ART protocol provides clear criteria to eliminate random errors, and to allow for an early response to relevant changes in target volumes.

Indexed as

adaptive radiotherapyhead and neck cancerhelical tomotherapyimage-guided radiation therapyradiotherapy planningreplanning

Identifiers

PMID35629389
PMCPMC9144703
OpenAlexW4280527347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.